John Licciardone

John Licciardone is a Regents Professor at the Texas College of Osteopathic Medicine (University of North Texas Health Science Center), holding the Richards-Cohen Distinguished Chair in Clinical Research. He directs the Osteopathic Research Center and the PRECISION Pain Research Registry, focusing on precision medicine and biopsychosocial approaches to pain management. His work emphasizes osteopathic manipulation, opioid prescribing optimization, and chronic pain prevention. He has led major NIH-funded trials, including the OSTEOPATHIC Trial and the PACBAC Trial.

Education: BS in Chemistry (Fordham University), DO (Kirksville College of Osteopathic Medicine), MS in Preventive Medicine (Ohio State University), MBA (Texas Christian University).

Research Interests: Chronic pain mechanisms, osteopathic manipulative treatment efficacy, pharmacogenetics for opioid safety, and patient-centered pain management strategies. His work bridges clinical practice and population health, with a focus on reducing opioid-related harms and advancing non-pharmacological therapies.

Awards include NIH Midcareer Investigator Award and recognition as a global expert in osteopathic manipulation by Expertscape. He collaborates with the NIH on federal pain research strategies and advises the World Health Organization on osteopathy regulation.

Grants/Projects: Co-Investigator in the $14M PACBAC Trial, NIH-funded studies on chronic low back pain, and multiple American Osteopathic Association grants evaluating osteopathic approaches to pain management.